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Abstract
Background: The purpose of this study was to examine the effects of a functional coffee beverage
containing additional caffeine, green tea extracts, niacin and garcinia cambogia to regular coffee to
determine the effects on resting energy expenditure (REE) and hemodynamic variables.
Methods: Subjects included five male (26 ± 2.1 y, 97.16 ± 10.05 kg, 183.89 ± 6.60 cm) and five
female (28.8 ± 5.3 y, 142.2 ± 12.6 lbs) regular coffee drinkers. Subjects fasted for 10 hours and were
assessed for 1 hour prior (PRE) and 3 hours following 1.5 cups of coffee ingestion [JavaFit™ Energy
Extreme (JF) ~400 mg total caffeine; Folgers (F) ~200 mg total caffeine] in a double-blind, crossover
design. REE, resting heart rate (RHR), and systolic (SBP) and diastolic (DBP) blood pressure was
assessed at PRE and 1, 2, and 3-hours post coffee ingestion. Data were analyzed by three-factor
repeated measures ANOVA (p < 0.05).
Results: JF trial resulted in a significant main effect for REE (p < 0.01), SBP (p < 0.01), RER (p <
0.01), and VO2 (p < 0.01) compared to F, with no difference between trials on the RHR and DBP
variables. A significant interaction for trial and time point (p < 0.05) was observed for the variable
REE. The JF trial resulted in a significant overall mean increase in REE of 14.4% (males = 12.1%,
females = 17.9%) over the observation period (p < 0.05), while the F trial produced an overall
decrease in REE of 5.7%. SBP was significantly higher in the JF trial; however, there was no significant
increase from PRE to 3-hours post.
Conclusion: Results from this study suggest that JavaFit™ Energy Extreme coffee is more effective
than Folgers regular caffeinated coffee at increasing REE in regular coffee drinkers for up to 3 hours
following ingestion without any adverse hemodynamic effects.
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Background
The popularity of thermogenic supplements containing
caffeine and other herbal products has increased over the
past few years. In the U.S., approximately 110 million
Americans drink coffee daily, while another 51 million
are occasional coffee drinkers. Coffee generally contains
caffeine in amounts ranging from 65–150 milligrams
depending on the type of coffee and the method of prep-
aration. Today, caffeine is appearing in many new prod-
ucts such as sports gels, energy drinks, and alcoholic
beverages to provide a thermogenic effect in an effort to
act as an ergogenic aid [1]. Even products that naturally
contain caffeine are being altered to increase the amount
of caffeine content. One of these products that have been
introduced to the market (JavaFit™ Energy Extreme) is a
new functional coffee beverage that contains 150 mg extra
caffeine per serving, green tea extract, garcinia cambogia
and niacin in an effort to produce a thermogenic product
that could have added benefits over regular coffee. This
new functional coffee is theorized to act as a thermogenic
aid and possibly have implications on elevating the meta-
bolic rate. Due to the popularity of daily coffee consump-
tion, the rationale of altering an existing product that is
used daily is sound.
Caffeine can have many effects in the body, but typically
caffeine is thought of as a way to boost an individual's
energy level on both a psychomotor level as well as a
physiological level as an ergogenic aid in high-intensity
and endurance exercise [2-5]. Caffeine has been identified
as one of the very few purported ergogenic aids that has a
significant effect on improving performance [1,6]. In
addition, caffeine has been shown to stimulate metabolic
rate in humans [7], so there could also be clinical implica-
tions for caffeine in the areas of weight loss and weight
management.
Like other stimulants, caffeine has been advertised and
sold as a way to stimulate energy expenditure and facili-
tate weight loss. Caffeine can stimulate both lipolysis and
energy expenditure [8,9]. Caffeine ingestion has been
studied alone and in conjunction with various herbal and
vitamin products like ephedra, green tea extracts, calcium,
tyrosine, chromium picolonate, capsaicin and garcinia
cambogia. An earlier study on caffeine and energy expend-
iture indicated that a single dose of 100 mg of caffeine had
a significant effect on resting metabolic rate (3–4%
increase over 150 min), suggesting that caffeine can have
a significant effect on energy balance at a commonly con-
sumed dose, and possibly have positive effects in the treat-
ment of obesity [10]. More recently, coffee ingestion (200
mg of caffeine) resulted in a 7% increase in energy
expenditure for three hours following ingestion [11].
Recent research on the effects of caffeine supports the role
of caffeine as a stimulus to increase total energy expendi-
ture. A recent study found that caffeine alone increased
energy expenditure by 13%, while doubling lipid turnover
[8].
Several reports have examined the role of caffeine and cof-
fee intake on a variety of diseases and health markers. It
has been reported that coffee consumption has no signif-
icant effects on the risk of coronary artery disease [12,13]
and may possibly even result in lower blood pressure on
a chronic basis [13-15]. One safety marker that has been
examined with caffeine or coffee intake is the effect on
blood pressure. Despite the research supporting that
chronic coffee intake could have a beneficial effect on
blood pressure, research has shown that changes in systo-
lic blood pressure are often observed following the acute
ingestion of caffeine with the addition of other herbal
products [16]. Many trials have shown this effect when
caffeine has been combined with the herbal product ephe-
dra [17,18]. A recent study also found increases in systolic
blood pressure following acute coffee ingestion, but it
should be noted that the combination of ingredients was
different from the coffee blend examined in this study
[16]. In addition, recent work has suggested that caffeine
does have a stimulatory effect on systolic blood pressure,
but the combination of other stimulants must be taken
into consideration as well [19]. Thus, the stimulatory
effects of caffeine on systolic blood pressure must be real-
ized when ingesting caffeine and other stimulatory prod-
ucts.
Research has supported the valuable role of caffeine in
metabolism and energy expenditure, and the safety of its
consumption. One possible method of incorporating
increased caffeine into daily consumption is to add it to
daily use products (functional beverages and/or foods).
The potential benefits could possibly include mainte-
nance and possible reductions in body weight by increas-
ing daily energy expenditure, which could have clinical
implications with the prevalence of obesity in our society.
This study is the first to examine the acute thermogenic
responses between JavaFit™ Energy Extreme (JF) and a reg-
ular caffeinated coffee (F). Therefore, the specific purpose
of this study was two-fold: 1) to assess the acute effects of
ingesting a single dose of an additional caffeine-contain-
ing coffee beverage on resting energy expenditure for three
hours after ingestion and 2) assess resting indices of
hemodynamic function and general side effects for three
hours after ingestion.
Methods
Subjects
Five physically active males (26 ± 2.1 y, 97.16 ± 10.05 kg,
183.89 ± 6.60 cm) and five females (28.8 ± 5.3 years,
64.64 ± 5.73 kg, 167.64 ± 7.37 cm) volunteered to partic-
ipate in this study. Subjects were between the ages 18–35
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and had to be regular coffee drinkers to participate in this
study. A regular coffee drinker was designated as one that
consumed at least 3 cups of coffee per week for at least one
year prior to the study. Average self-reported daily caffeine
intake for all subjects was 274.29 ± 53.22 milligrams per
day. Subjects were not currently (or in the past 3 months)
taking dietary supplements containing creatine, arginine,
androstendione, thermogenics, or any other nutritional
supplement. Subjects that were eligible were informed of
the requirements of the study and signed an informed
consent statement in compliance with the Institutional
Review Board for the Protection of Human Subjects in
Research guidelines of Baylor University.
Study design
This study was conducted as a randomized, double blind,
crossover design that was counterbalanced for the admin-
istration of two experimental trials. Subjects were famil-
iarized one week prior to the start of testing. During the
familiarization session, subjects completed a health his-
tory questionnaire, personal information sheet and
signed an informed consent form. In addition, the sub-
jects were verbally instructed on the study design and the
requirements for each testing session. Subjects reported
for first testing session on a 10-hour fast and were
instructed to refrain from exercise and caffeine consump-
tion 24 hours prior to each testing session. Subjects'
height was assessed using standard anthropometry and
total body weight was measured using a calibrated elec-
tronic scale with a precision of ± 0.02 kg (Bridgeview, Illi-
nois). Subjects were then instructed to lie in a supine
position for 1 hour. At the end of the 1-hour period, base-
line resting energy expenditure (REE), heart rate (HR) and
blood pressure (SBP and DBP) were assessed. Following
the baseline assessment, subjects were randomly assigned
to drink 1.5 cups (354 milliliters) of either JavaFit™ Energy
Extreme (JF) coffee [~400 mg of total caffeine, 600 mg
green tea extracts (EGCG), <15 mg of garcinia cambogia
and ~30 mg of niacin] or Folgers Regular (F) coffee [~200
mg of caffeine]. The coffee was prepared using 65 milli-
grams of the respective coffee with 354 milliliters of dis-
tilled water using standard drip-brewed methods 20
minutes prior to the start of each individual trial. Subjects
were required to ingest the entire amount of black coffee
in 15 minutes. Following ingestion, subjects rested in a
supine position for 3 hours in which REE, HR, SBP and
DBP were assessed in the last 20 minutes of each observa-
tion hour following the ingestion of the coffee. Following
the 3-hour assessment period, subjects completed a side
effects questionnaire to assess any possible adverse reac-
tions from the coffee ingestion. Subjects reported to the
lab one week later for the second session of the crossover
design using the other coffee and repeated the 4-hour test-
ing protocol.
REE and hemodynamic assessment
Resting energy expenditure was assessed using a Parvo
Medics' TrueOne® 2400 (ParvoMedics, Sandy, UT) inte-
grated metabolic measurement system. Metabolic carts
were calibrated everyday 30 minutes prior to the begin-
ning of testing. Resting energy expenditure was measured
in a supine position and REE values were calculated dur-
ing the final 10 minutes of each 1-hour session to ensure
each subject had stabilized to a resting state. Resting heart
rate was assessed in the supine position with wireless
Polar heart rate monitors (Polar Electro Inc., Lake Success,
NY) using standard procedures at the end of each observa-
tion hour. Resting blood pressure was assessed in the
supine position using a mercurial sphygmomanometer
using standard procedures at the end of each observation
hour.
Dietary records
The subjects' diets were not standardized and subjects
were asked not to change their dietary habits during the
course of the study with the exception of limiting their caf-
feine intake 24 hours prior to each testing session. How-
ever, subjects were required to keep dietary records for the
24 hours prior to each testing session of the crossover
design to evaluate their daily macronutrient intake for car-
bohydrate, fat, protein and total calories. The dietary
records were evaluated with the Food Processor dietary
assessment software program (ESHA Research Inc., Salem,
OR).
Side effects assessment
The possible side effects of the two coffees were assessed
with a Side Effects Questionnaire (Table 1). Variables that
were addressed included: dizziness, headache(s), fast or
racing heart rate, heart skipping or palpitations, shortness
of breath, nervousness, blurred vision, as well as a self-
report of any other unusual or adverse effects. The ques-
tionnaire assessed both the frequency of occurrence for
each variable, as well as severity of these variables at the
time the questionnaire.
Statistical analysis
Dependent variables were analyzed by utilizing separate
three-factor [coffee (F or JF) × gender (M or F) × time point
(PRE & 1, 2, 3 hours post-ingestion)] factorial analyses of
variance (ANOVA) with repeated measures for each crite-
rion variable. In addition, the within trial changes for REE
were analyzed with dependent t-tests. Data obtained from
the Side Effects Questionnaire were analyzed with sepa-
rate ANOVA's for each respective variable. Significant
between-group differences were determined involving the
Neuman-Keuls Post Hoc Test. All statistical procedures
were performed using SPSS 11.0 software and a probabil-
ity level of < 0.05 was adopted throughout. All data are
reported as means ± standard deviation.
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Results
Energy expenditure measures
The REE responses between the two coffee trials indicated
that there was a significantly higher elevation in REE over
the 3-hour observation period during the JF trial. Signifi-
cant main effects for trial (p < 0.01) and gender (p < 0.01)
for the variable REE were observed indicating that the JF
trial and the males had an overall higher REE. In addition,
a significant interaction for trial and time point (p < 0.05)
was observed for the variable REE. Dependent t-tests sup-
ported these findings indicating a significant increase in
REE from PRE to 3-hours post (p < 0.01) in the JF trial,
while the F trial showed a trend (p = 0.058) for a signifi-
cant decrease in REE from PRE to 3-hours post. Mean val-
ues at PRE and 3-hours post for the variable REE were
1,932.83 ± 370.25 and 1,822.91 ± 323.09 kcal for the F
trial and 1,858.23 ± 412.89 and 2179.75 ± 424.34 kcal for
the JF trial (see Figure 1), respectively. This change in REE
from PRE to 3-hours post represents an overall average
increase in REE for both genders of 14.4% (males =
12.1%, females = 17.9%) in the JF trial, whereas a decrease
in REE of 5.7% from the PRE to 3-hour post observation
period was observed in the F trial.
REE response to coffee ingestionFigu  1
REE response to coffee ingestion. Change in supine rest-
ing energy expenditure (mean ± SD) between two trials 
(broken line = F, solid line = JF) from pre to 3-hours follow-
ing coffee ingestion. * = significant main effect for trial (p < 
0.05). † = a significant main effect for gender (p < 0.01). ‡ = a 
significant interaction for trial and time point (p < 0.05).
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Table 1: Side-effects questionnaire that was administered following each coffee trial.
Testing Session Baseline T1 T2
Did you consume all the coffee?
Rate the frequency of the following symptoms according to the scale where:
0 = none
1 = minimal
2 = slight
3 = occasional
4 = frequent
5 = severe
Dizziness?
Headache?
Fast or racing heart rate?
Heart skipping or palpitations?
Shortness of breath?
Nervousness?
Blurred Vision?
Any other unusual or adverse effects?
Rate the severity of the following symptoms according to the scale where:
0 = none
1 = minimal
2 = slight
3 = moderate
4 = severe
5 = very severe
Dizziness?
Headache?
Fast or racing heart rate?
Heart skipping or palpitations?
Shortness of breath?
Nervousness?
Blurred Vision?
Any other unusual or adverse effects?
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In accordance with the differences observed in REE, signif-
icant main effects for trial (p < 0.01) and gender (p < 0.01)
were observed for resting VO2 indicating that the JF trial
and that the females had a higher resting VO2, with no sig-
nificant differences for time point or interaction effects.
Overall mean values at PRE and 3-hours post for the vari-
able VO2 were 3.55 ± 0.39 and 3.35 ± 0.47 ml/kg/min for
the F trial and 3.44 ± 0.36 and 3.96 ± 0.44 ml/kg/min for
the JF trial (see Figure 2), respectively. These results show
a 15.1% elevation in resting VO2 from PRE to 3-hours post
in the JF trial, while the resting VO2 in the F trial decreased
5.6% over the 3-hour observation period.
As for the variable resting RER, a significant main effect for
resting RER (p < 0.01) was observed indicating that the JF
trial had an overall lower RER, with no significant differ-
ences for time point, gender or interaction effects. Overall
mean values at PRE and 3-hours post for the variable RER
were 0.809 ± 0.056 and 0.759 ± 0.046 for the F trial and
0.745 ± 0.039 and 0.762 ± 0.061 for the JF trial (see Figure
3), respectively. These results represent a 2.3% elevation
in resting RER from PRE to 3-hours post in the JF trial,
while the resting RER in the F trial decreased 6.2% over
that 3-hour observation period.
Hemodynamic measures
Hemodynamic markers were observed to examine the
effect of the two coffee trials. Significant main effects for
trial (p < 0.01) and gender (p < 0.01) were observed for
resting SBP indicating that the JF trial had an overall
higher SBP and the females had a lower SBP than males,
with no significant differences for time point or interac-
tion effects. Mean values at PRE and 3-hours post for the
variable SBP were 110.0 ± 7.48 and 106.8 ± 6.33 for the F
trial and 112.0 ± 5.8 and 113.4 ± 6.33 for the JF trial (see
Figure 4), respectively. SBP was significantly higher in the
JF trial, however the ingestion of the JF coffee did not sig-
nificantly increase SBP over time during the PRE to 3-hour
post observation period (p = 0.61). These results show a
1.3% elevation in resting SBP from PRE to 3-hours post in
the JF trial, while the resting SBP in the F trial decreased
2.9% over that 3-hour observation period.
Additional hemodynamic markers assessed in this study
included HR and DBP. A significant main effect for gender
(p < 0.01) was observed for resting DBP indicating that
the females had a lower resting DBP than the males, with
no significant differences for time point or interaction
effects (see Figure 5). The results of this study indicated
that there were no significant interactions or main effects
SBP response to coffee ingestionFigure 4
SBP response to coffee ingestion. Change in supine rest-
ing SBP (mean ± SD) between two trials (broken line = F, 
solid line = JF) from pre to 3-hours post coffee ingestion. * = 
significant main effect for trial (p < 0.05). † = a significant 
main effect for gender (p < 0.01).
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Resting VO2 response to coffee ingestionFigure 2
Resting VO2 response to coffee ingestion. Change in 
supine resting VO2 (mean ± SD) between two trials (broken 
line = F, solid line = JF) from pre to 3-hours post coffee 
ingestion. * = significant main effect for trial (p < 0.05). † = a 
significant main effect for gender (p < 0.01).
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RER response to coffee ingestionFigu  3
RER response to coffee ingestion. Change in supine rest-
ing RER (mean ± SD) between two trials (broken line = F, 
solid line = JF) from pre to 3-hours post coffee ingestion. * = 
significant main effect for trial (p < 0.05). † = a significant 
main effect for gender (p < 0.01).
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for trial, gender or time (p > 0.05) for resting HR (see Fig-
ure 6). These data suggest that the consumption of both F
and JF have no affect on resting HR and DBP for 3-hours
following ingestion.
Nutritional analysis
No significant changes in 24-hour dietary recalls were
observed between subjects for macronutrient content of
protein (g), carbohydrates (g), fat (g) and total caloric
intake (kcal) (see Table 2), or caffeine ingestion prior to
each respective trial (F or JF).
Side effects
Subjects completed a Side Effects Questionnaire following
both 4-hour testing sessions to assess any potential side
effects of the coffee (caffeine) ingestion (Table 1). No sig-
nificant differences were observed for the frequency of
occurrence or for the severity of the side effects dizziness,
headache, fast or racing heart rate, heart skipping or palpi-
tations, shortness of breath, nervousness and blurred
vision. One female subject reported light-headedness at
the end of the 3-hour observation period, but this was
reported following both testing sessions of the crossover
design, and was more likely due to the duration of the
fasting condition associated with each session.
Discussion
The major findings of this study suggest that drinking cof-
fee containing approximately 400 mg total caffeine (an
additional 150 mg per serving compared to regular, caf-
feinated coffee), green tea extract, garcinia cambogia and
niacin does have significant effects on resting energy
expenditure compared to normal caffeinated coffee for 3-
hours following ingestion in healthy and physically
active, regular coffee drinkers. The significant difference in
REE between the two trials occurred with a slight differ-
ence in SBP, while resting HR and DBP were not affected
by the addition of 200 mg of caffeine over regular, caffein-
ated coffee, as well as the additional herbal ingredients
that are present in the experimental coffee (JF).
Previous research has supported the notion that acute caf-
feine and/or coffee ingestion can have significant effects
on REE. These previous findings have shown increases in
REE over 2 to 3-hour time periods following ingestion and
have utilized various combinations of caffeine combined
with additional ingredients including ephedra, black tea,
garcinia cambogia, citrus aurantium and chromium
polynicotinate [16,20,21]. Caffeine has been the common
ingredient in all of these studies and caffeine alone has
been demonstrated to affect REE in human studies
[7,8,10,11]. This is important because another previously
studied ingredient (ephedra) that has been combined
with caffeine is not overly available on the market and
now other ingredients are being combined with caffeine
to determine if they can alter the metabolic rate following
ingestion. This study examined a functional coffee bever-
age that has 150 mg of additional caffeine per serving as
well as an herbal combination of green tea extracts, gar-
cinia cambogia and niacin. This is the first study to exam-
ine the acute changes in metabolic rate using this type of
functional coffee. Our findings suggesting that consump-
tion of JF can have significant effects on REE are in agree-
ment with previous research indicating that caffeine,
coffee and green tea have been shown to have positive
effects on REE in humans [7,8,10,11,16,22]. Knowing the
effects that caffeine and green tea extracts can have on the
metabolic rate, the increases in REE observed in this study
are likely a result of adding additional caffeine and green
tea extracts that were not present in the regular coffee trial.
In addition, the relatively small amounts of garcinia cam-
RHR response to coffee ingestionFigur  6
RHR response to coffee ingestion. Change in supine 
resting RHR (mean ± SD) between two trials (broken line = 
F, solid line = JF) from pre to 3-hours post coffee ingestion.
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DBP response to coffee ingestionFigu  5
DBP response to coffee ingestion. Change in supine 
resting DBP (mean ± SD) between two trials (broken line = 
F, solid line = JF) from pre to 3-hours post coffee ingestion. † 
= a significant main effect for gender (p < 0.01).
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bogia and niacin are probably not significant enough to
affect any of the variables measured in this study. Garcinia
cambogia has been studied as a possible means of increas-
ing metabolism and promoting weight loss, but research
has not supported these proposed benefits [23].
In the current study, the JF trial had a significantly lower
RER when compared to the F trial. However, no signifi-
cant changes were observed over time for RER, thus these
findings suggest that fuel oxidation was not significantly
affected by the experimental coffee trial. Our findings do
not agree with a recent study that utilized a similar coffee
blend containing additional caffeine, citrus aurantium
and chromium polynicotinate which reported a signifi-
cantly higher RER in the experimental coffee over placebo
[16]. These differences are most likely attributed to the
differences in the added ingredients to the coffee blend
(i.e., green tea extracts and niacin vs. citrus aurantium and
chromium polynicotinate).
The alterations in REE and RER were observed in the pres-
ence of a significantly higher resting VO2 in the JF trial.
Resting VO2 increased 15.1% from PRE to 3-hour post
time point, while the VO2 of the F trial decreased 5.6%
over the same time period. Despite these changes, the
interaction effect for trial and time point for the variable
VO2 only showed a trend for significance (p = 0.06), thus
we cannot suggest that the JF trial elicited a higher VO2
response over the 3-hour observation period. However,
these findings in conjunction with the significant eleva-
tions in REE do suggest that ingestion during the JF trial
positively affects oxidative metabolism in the body in
comparison to the F trial.
An increase in SBP is an occurrence that has previously
been associated with the ingestion of products containing
caffeine and/or herbal ingredients [16,18,19]. The find-
ings of this study found a significantly higher SBP in the
JF trial. Despite the significant difference, the small
increase over time (1.3%) was not a significant elevation.
It should be noted that the JF coffee compared to the reg-
ular coffee (F) did have approximately 150 mg more caf-
feine per serving, and the F trial did demonstrate a
decrease (2.9%) in SBP over the same time period. It is
likely that the additional caffeine and possibly the green
tea extracts contained in the JF coffee resulted in the small
sustained increases in SBP over time. In addition to the
SBP responses, the hemodynamic variables resting HR
and DBP were not affected by either of the coffees, which
are in agreement with previous research [16,24].
Caffeine consumption has traditionally been associated
with other issues concerning health; however the claims
seem to not be supported. As for blood pressure, caffeine
consumption has been linked to acute increases in blood
pressure, but habitual coffee consumption does not seem
have adverse effects on blood pressure [15]. However,
some studies do suggest that individuals that already have
existing high blood pressure issues may benefit from
reducing or restricting coffee intake in these populations
[25,26]. Overall, habitual coffee consumption does not
seem to lead to negative effects on blood pressure unless
there is a pre-existing problem with high blood pressure.
Diabetes is another area of health that has been studied in
its relationship to caffeine/coffee consumption. Studies
suggest that coffee drinking is associated with a higher
insulin sensitivity and a lower risk of type 2 diabetes [27-
31], and that total caffeine intake from all sources was
associated with a significantly lower risk for diabetes in
men and women [29]. In addition, various studies have
found no negative relationship between caffeine, coffee or
tea consumption with the following types of cancer:
breast cancer [32], oral/pharyngeal and esophageal cancer
[33], colon cancer [34], epithelial ovarian cancer [35],
liver cancer [36], thyroid cancer [37] and pancreatic can-
cer [38] in various populations. Thus, the overall health
implications with caffeine and coffee consumption do not
seem to have a negative effect on health and the possible
positive effects on REE and metabolism show potential in
the areas of weight management and weight loss.
Conclusion
The major findings of this study indicate that the con-
sumption of 1.5 cups of a functional coffee beverage con-
taining approximately 400 mg caffeine (150 mg
additional caffeine per serving compared to regular, caf-
feinated coffee), green tea extracts, garcinia cambogia and
niacin can significantly increase the resting energy
expenditure over a 3-hour time period in comparison to
regular caffeinated coffee. These findings could have
Table 2: Self-reported 24-hour dietary recall analysis (mean ± SD) between two trials.
Variable F JF Significance
Protein (g) 169 ± 57 171 ± 59 p = 0.998
Fat (g) 56 ± 18 54 ± 20 p = 0.959
Carbohydrates (g) 326 ± 108 319 ± 112 p = 0.939
Total Calories (kcal) 2,478 ± 841 2,458 ± 828 p = 0.96
Data are means and ± standard deviations
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potential clinical implications in the area of weight main-
tenance and weight loss. However, the implications of caf-
feine intake on other processes in the body must not be
discounted and should be taken into consideration before
this is considered a possible path for improving weight
maintenance and weight loss. Despite the overall differ-
ence between trials, SBP was not affected over time with
the additional caffeine consumption present in the JF cof-
fee. Resting HR and DBP were not affected with ingestion
of either of the two coffees and both coffees were well tol-
erated with no significant reported side effects following
ingestion. Future research needs to be conducted to exam-
ine the chronic effects of this product to see if it has impli-
cations in weight loss and/or weight maintenance
resulting from the acute increases in resting energy
expenditure.
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